PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES
CY1125967T1Undetermined Publication Date: 2026-07-31BIOGEN MA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100200T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-08-22
- Filing Date
- 2023-04-24
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-04-24
Abstract
Pharmaceutical compositions containing anti-beta amyloid (AP) antibodies or AP-binding fragments thereof are provided. These pharmaceutical compositions are used in the treatment of abnormal accumulation or deposition of AP in the central nervous system, mild cognitive impairment, and AP-related disorders, such as Alzheimer's disease.
Need to check novelty before this filing date? Find Prior Art